Abstract

The purpose of this article is to analyze the range of medicines that are used in the treatment of skin diseases. This topic is currently relevant, since the analysis of retail sales allows you to assess the financial condition of a pharmacy organization, identify unclaimed drugs, develop measures to stimulate sales, as well as study customer demand and develop a strategy for product movement. Accordingly, conducting a study of the main indicators of the assortment of this group of drugs will make it possible to expand their representation on the shelves of pharmacies, as well as to study the demand for them from potential consumers.
 During the analysis, the following data were obtained. The range under study was represented in the pharmacy by 22 items. The analysis of dosage forms of medicines intended for the treatment of skin diseases showed that liquid dosage forms accounted for 22.73%; solid dosage forms - 4.55%; soft dosage forms – 59.08%; gaseous dosage forms -13.64%. When analyzing the drugs, it was revealed that the largest number in the assortment is synthetic drugs - 68.18%; the share of phytopreparations was 31.82%. Analysis of the producing countries showed that most of the drugs presented to the pharmacy by domestic producers (54,53%), in the second place drugs manufactured in India -18,17%; third place was shared by countries: Poland, Croatia, Belgium, Germany, Czech Republic, USA -4,55%. The analysis of price categories of pharmaceuticals for the treatment of skin diseases revealed that in the price category from 100 to 200 RUB presents 22,73% of drugs; in the category from 200 to 300 rubles-49,89%; from 300 to 400 rubles from 33.73%; from 400 to 700 rubles - on 4,55%.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call